Clinical Trial Update: To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial is evaluating the efficacy and safety of co-administered HODO-2224-1 and HODO-2224-2 in adults with essential hypertension and prima…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia Primary
• Hypertension

Drugs mentioned

• HODO-2224-1
• HODO-2224-2

Snippet

Sponsor: Hyundai Pharm | Conditions: Hypertension, Primary Hypercholesterolaemia | Phase 3 | Status: ENROLLING_BY_INVITATION